Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Artificial Vital Organs and Medical Bionics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global artificial vital organs and medical bionics market size reached US$ 41.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.67 Billion by 2027, exhibiting a growth rate (CAGR) of 6.50% during 2022-2027.

Artificial vital organs are engineered devices that can be implanted into the human body for replacing a natural organ. They reduce the harmful impact of damaged organs while patients wait for organ transplants. On the other hand, medical bionics is a multidisciplinary field of research for developing implantable devices, which are designed to provide long-term safety and effective sensory or motor function to nerve or muscle tissues. They are used to develop cloned liver cells that filter toxins from the plasma and secrete albumin proteins and clotting factors like a normal liver. They also assist in designing an intravenous membrane oxygenator (IMO), which is integrated directly within the vena cava system to oxygenate the blood as it returns to the heart before reaching the natural lungs.

Artificial Vital Organs and Medical Bionics Market Trends:

At present, there is a rise in the prevalence of various diseases, such as respiratory ailments, cirrhosis, and heart, kidney, and liver failures. This, along with the burgeoning healthcare industry, represents one of the key factors driving the market. Besides this, the increasing geriatric population that is highly prone to organ disorders across the globe is contributing to the growth of the market. In addition, the growing development of novel products, such as full-functioning artificial hearts, livers, lungs, urethras, windpipes, and livers, is positively influencing the market. Moreover, key market players are extensively investing in research and development (R&D) activities to introduce new techniques of organ regeneration through engineered tissues, which is offering a positive market outlook. Apart from this, the rising demand for artificial organs due to the development of bioartificial organs with improved survival rates and faster recuperation of patients is propelling the growth of the market. Additionally, the implementation of life-saving technologies, such as the bridge to transplant and the bridge to recovery in critical cases, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial vital organs and medical bionics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and application.

Breakup by Product Type:

  • Artificial Vital Organs
    • Artificial Liver
    • Artificial Heart
    • Artificial Pancreas
    • Artificial Kidney
    • Artificial Lungs
    • Oxygenators
  • Medical Bionics
    • Bionic Limbs
    • Vision Bionics
    • Ear Bionics
    • Exoskeletons
    • Brain Bionics
    • Heart Valves
    • Cardiac Bionics
       

Breakup by Application:

  • Hospitals
  • Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abiomed, BiVACOR Inc, CARMAT, Cirtec Medical, Edwards Lifesciences, Ekso Bionics Holdings Inc., Nikkiso Co. Ltd., Second Sight Medical Products Inc and SynCardia Systems LLC (Picard Medical Inc.).

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product Type, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abiomed, BiVACOR Inc, CARMAT, Cirtec Medical, Edwards Lifesciences, Ekso Bionics Holdings Inc., Nikkiso Co. Ltd., Second Sight Medical Products Inc and SynCardia Systems LLC (Picard Medical Inc.).
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global artificial vital organs and medical bionics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global artificial vital organs and medical bionics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial vital organs and medical bionics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Artificial Vital Organs and Medical Bionics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Artificial Vital Organs
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Artificial Liver
           6.1.2.2 Artificial Heart
           6.1.2.3 Artificial Pancreas
           6.1.2.4 Artificial Kidney
           6.1.2.5 Artificial Lungs
           6.1.2.6 Oxygenators
        6.1.3 Market Forecast
    6.2    Medical Bionics
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Bionic Limbs
           6.2.2.2 Vision Bionics
           6.2.2.3 Ear Bionics
           6.2.2.4 Exoskeletons
           6.2.2.5 Brain Bionics
           6.2.2.6 Heart Valves
           6.2.2.7 Cardiac Bionics
        6.2.3 Market Forecast
7    Market Breakup by Application
    7.1    Hospitals
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Clinics
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Abiomed 
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    BiVACOR Inc
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
        13.3.3    CARMAT
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
        13.3.4    Cirtec Medical
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
        13.3.5    Edwards Lifesciences
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Ekso Bionics Holdings Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Nikkiso Co. Ltd.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Second Sight Medical Products Inc
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
        13.3.9    SynCardia Systems LLC (Picard Medical Inc.)
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 SWOT Analysis

List of Figures

Figure 1: Global: Artificial Vital Organs and Medical Bionics Market: Major Drivers and Challenges
Figure 2: Global: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Product Type (in %), 2021
Figure 5: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Application (in %), 2021
Figure 6: Global: Artificial Vital Organs and Medical Bionics Market: Breakup by Region (in %), 2021
Figure 7: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Artificial Vital Organs and Medical Bionics (Artificial Vital Organs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Artificial Vital Organs and Medical Bionics (Medical Bionics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Artificial Vital Organs and Medical Bionics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Artificial Vital Organs and Medical Bionics (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Artificial Vital Organs and Medical Bionics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: North America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: North America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: United States: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: United States: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Canada: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Canada: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Asia-Pacific: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: China: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: China: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Japan: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Japan: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: India: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: India: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: South Korea: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: South Korea: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Australia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Australia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Indonesia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Indonesia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Europe: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Europe: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Germany: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Germany: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: France: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: France: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United Kingdom: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United Kingdom: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Italy: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Italy: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Spain: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Spain: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Russia: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Russia: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Latin America: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Latin America: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Brazil: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Brazil: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Mexico: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Mexico: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market: Breakup by Country (in %), 2021
Figure 65: Middle East and Africa: Artificial Vital Organs and Medical Bionics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Global: Artificial Vital Organs and Medical Bionics Industry: SWOT Analysis
Figure 67: Global: Artificial Vital Organs and Medical Bionics Industry: Value Chain Analysis
Figure 68: Global: Artificial Vital Organs and Medical Bionics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Artificial Vital Organs and Medical Bionics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Artificial Vital Organs and Medical Bionics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Artificial Vital Organs and Medical Bionics Market: Competitive Structure
Table 6: Global: Artificial Vital Organs and Medical Bionics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4